Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Medical Screening|August 27, 2020
Breast-cancer mortality in screened versus unscreened women: Long-term results from a population-based study in Queensland, AustraliaNathan Dunn, Philippa Youl, Julie Moore, et al.
Internal Medicine Journal|May 6, 2020
Bortezomib use and outcomes for the treatment of multiple myelomaCrystal Loke, Peter Mollee, Ian McPherson, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2003
Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigenMark Smithers, Kathleen O'Connell, Susan MacFadyen, et al.
Medical Oncology (Northwood, London, England)|February 20, 2014
Toxicity and tolerability of adjuvant breast cancer chemotherapy in obese womenJames P Carroll, Melinda M Protani, Linda Nguyen, et al.
Asia Pacific Journal of Clinical Nutrition|October 2, 2018
Serum vitamin D decreases during chemotherapy: an Australian prospective cohort studyElizabeth A Isenring, Laisa Teleni, Richard J Woodman, et al.
Asia-Pacific Journal of Clinical Oncology|March 22, 2016
Indigenous Australians with non-small cell lung cancer or cervical cancer receive suboptimal treatmentLisa J Whop, Christina M Bernardes, Srinivas Kondalsamy-Chennakesavan, et al.
Internal Medicine Journal|May 14, 2019
Are general practitioners getting the information they need from hospitals and specialists to provide quality cancer care for Indigenous Australians?Patricia C Valery, Christina M Bernardes, Audra de Witt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 4, 2019
Patterns of primary health care service use of Indigenous Australians diagnosed with cancerPatricia C Valery, Christina M Bernardes, Audra de Witt, et al.
Clinical Pharmacokinetics|February 9, 2020
Inability of Current Dosing to Achieve Carboplatin Therapeutic Targets in People with Advanced Non-Small Cell Lung Cancer: Impact of Systemic Inflammation on Carboplatin Exposure and Clinical OutcomesBenjamin D W Harris, Viet Phan, Vidya Perera, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2017
Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanomaTeresa M Petrella, Caroline Robert, Erika Richtig, et al.
Pageof 4